A genetic model for central chondrosarcoma evolution correlates with patient outcome
A genetic model for central chondrosarcoma evolution correlates with patient outcome
About this item
Full title
Author / Creator
Genomics England Research Consortium , Cross, William , Lyskjær, Iben , Lesluyes, Tom , Hargreaves, Steven , Strobl, Anna-Christina , Davies, Christopher , Waise, Sara , Hames-Fathi, Shadi , Oukrif, Dahmane , Ye, Hongtao , Amary, Fernanda , Tirabosco, Roberto , Gerrand, Craig , Baker, Toby , Barnes, David , Steele, Christopher , Alexandrov, Ludmil , Bond, Gareth , Cool, Paul , Pillay, Nischalan , Van Loo, Peter and Flanagan, Adrienne M
Publisher
England: BioMed Central Ltd
Journal title
Language
English
Formats
Publication information
Publisher
England: BioMed Central Ltd
Subjects
More information
Scope and Contents
Contents
Central conventional chondrosarcoma (CS) is the most common subtype of primary malignant bone tumour in adults. Treatment options are usually limited to surgery, and prognosis is challenging. These tumours are characterised by the presence and absence of IDH1 and IDH2 mutations, and recently, TERT promoter alterations have been reported in around 2...
Alternative Titles
Full title
A genetic model for central chondrosarcoma evolution correlates with patient outcome
Authors, Artists and Contributors
Author / Creator
Cross, William
Lyskjær, Iben
Lesluyes, Tom
Hargreaves, Steven
Strobl, Anna-Christina
Davies, Christopher
Waise, Sara
Hames-Fathi, Shadi
Oukrif, Dahmane
Ye, Hongtao
Amary, Fernanda
Tirabosco, Roberto
Gerrand, Craig
Baker, Toby
Barnes, David
Steele, Christopher
Alexandrov, Ludmil
Bond, Gareth
Cool, Paul
Pillay, Nischalan
Van Loo, Peter
Flanagan, Adrienne M
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_ffacb8a0eb7048c79fcc4c60653e1002
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_ffacb8a0eb7048c79fcc4c60653e1002
Other Identifiers
ISSN
1756-994X
E-ISSN
1756-994X
DOI
10.1186/s13073-022-01084-0
